1. Home
  2. NOAH vs MGTX Comparison

NOAH vs MGTX Comparison

Compare NOAH & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOAH
  • MGTX
  • Stock Information
  • Founded
  • NOAH 2005
  • MGTX 2015
  • Country
  • NOAH China
  • MGTX United States
  • Employees
  • NOAH N/A
  • MGTX N/A
  • Industry
  • NOAH Investment Managers
  • MGTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NOAH Finance
  • MGTX Health Care
  • Exchange
  • NOAH Nasdaq
  • MGTX Nasdaq
  • Market Cap
  • NOAH 750.3M
  • MGTX 622.0M
  • IPO Year
  • NOAH 2010
  • MGTX N/A
  • Fundamental
  • Price
  • NOAH $11.97
  • MGTX $8.89
  • Analyst Decision
  • NOAH Buy
  • MGTX Strong Buy
  • Analyst Count
  • NOAH 2
  • MGTX 2
  • Target Price
  • NOAH $12.25
  • MGTX $24.00
  • AVG Volume (30 Days)
  • NOAH 178.5K
  • MGTX 540.6K
  • Earning Date
  • NOAH 08-27-2025
  • MGTX 08-11-2025
  • Dividend Yield
  • NOAH 4.85%
  • MGTX N/A
  • EPS Growth
  • NOAH N/A
  • MGTX N/A
  • EPS
  • NOAH 0.96
  • MGTX N/A
  • Revenue
  • NOAH $353,619,651.00
  • MGTX $34,508,000.00
  • Revenue This Year
  • NOAH N/A
  • MGTX $365.04
  • Revenue Next Year
  • NOAH $6.50
  • MGTX $73.18
  • P/E Ratio
  • NOAH $12.73
  • MGTX N/A
  • Revenue Growth
  • NOAH N/A
  • MGTX 203.23
  • 52 Week Low
  • NOAH $7.21
  • MGTX $3.85
  • 52 Week High
  • NOAH $14.90
  • MGTX $8.91
  • Technical
  • Relative Strength Index (RSI)
  • NOAH 54.22
  • MGTX 79.45
  • Support Level
  • NOAH $11.79
  • MGTX $6.31
  • Resistance Level
  • NOAH $12.26
  • MGTX $8.75
  • Average True Range (ATR)
  • NOAH 0.34
  • MGTX 0.45
  • MACD
  • NOAH -0.08
  • MGTX 0.20
  • Stochastic Oscillator
  • NOAH 55.63
  • MGTX 99.11

About NOAH Noah Holdings Limited

Noah Holdings Ltd is a wealth management service provider offering comprehensive advisory services on investment and asset allocation, mainly for Mandarin-speaking high-net-worth (HNW) investors. The company's operating segments are Domestic public securities, Domestic asset management, Domestic insurance, Overseas wealth management, Overseas asset management, Overseas insurance and comprehensive services, and Headquarters. Maximum revenue is generated from its Domestic asset management business, which manages private equity funds, real estate equity funds, and private secondary products. The domestic asset management operations focus on managing primary market exits and cross-border ETF products in the secondary market. Geographically, it derives maximum revenue from Mainland China.

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.

Share on Social Networks: